| Future Health Pharma GmbH - Actonel 35 mg Wochentabletten, Filmtabletten | | 55214 | | 03 | | Actonel 35 mg Wochentabletten | | Filmtabletten | | M05BA07 | | Risedronsäure | | 27.06.2002 | | |
| | Composition | | natrii risedronas 35.0 mg corresp. natrium 2.64 mg, lactosum monohydricum 126.0 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, hydroxypropylcellulosum, macrogolum 8000, silica colloidalis anhydrica, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Sodium Risedronate | 35 mg correspond Sodium 2.64 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Sodium Risedronate | 35 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 126 mg | | | Macrogol | 8000 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 009 | 4 Comprimé(s) | 15.44 | 33.20 | B | LS | Non | | 011 | 12 Comprimé(s) | 43.53 | 63.75 | B | LS | Non |
|
|
